Human-anti-human cd3 binding molecules

US8784821B1 · kind B1 · utility

Assignee

• AMGEN RESEARCH (MUNICH) GMBH · DE

Inventors

• Peter Kufer · Munich, DE
• Tobias Raum · Munich, DE
• Meera Berry · Ulm, DE
• Roman Kischel · Munich, DE
• Susanne Mangold · Munich, DE
• Eva Krinner · Munich, DE
• Birgit Kohleisen · Munich, DE
• Steven Zeman · Zell (Mosel), DE
• Christian Itin · Menlo Park, US
• Patrick Bauerle · Gauting, DE

Key dates

• Filing date: May 26, 2004
• Grant date: Jul 22, 2014
• Expiry date: May 14, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/34
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a method for the preparation of a human binding molecule, fragment or derivative thereof which specifically binds to the human CD3 complex. Furthermore, the invention provides a human binding molecules specifically binding to the human CD3 complex and means comprising said human binding molecules.